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Background
Bisphosphonates are the mainstay of pharmacologic
fracture-prevention therapy for most forms of osteogen-
esis imperfecta (OI). Studies suggests that bisphospho-
nate treatment may significantly improve the natural
history of all type of OI, particularly by decreasing the
rate of fracture, increasing bone mineral density,
decreasing bone pain, and significantly increasing height.
Objective
To evaluate the effect of bisphosphonate treatment in
OI children treated in Cipto Mangunkusumo Hospital
(CMH) Jakarta.
Method
We retrospectively studied the data of age, gender, age
at diagnosis, bisphosphonate treatment, and its effects in
OI patients in CMH from Indonesian OI children regis-
try, which is documented from January 2012 to May
2014.
Results
Seventy-seven OI cases (39 male), which were diagnosed
at the age of 1 - 9 years old were recorded. Five patients
underwent surgery and three patients died before com-
mencing treatment. Nine patients received intravenous
pamidronate and sixteen patients received zolendronic
acid therapy. Liver and renal functions, as well as serum
electrolyte levels were evaluated before and after treat-
ment. Eight patients reported hyperthermia and three
others experienced fatigue, bone pain, and abdominal
pain within 24 hours of therapy. Serum calcium level
decreased in eight patients. No serious adverse effects
were documented.
Conclusions
All registered OI cases patients that received bispho-
sphonates treatment showed no serious adverse effects.
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